TheraCryf PLC (TCF)

Ticker: TCF Exchange: LSE


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 5 Apr 2024
Value £1,076,292.65 | Price 489.32 | Shares 20,445
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2024-04-05 2024-04-05 B Purchase Dr Nicholas Mallard

PDMR

20,445
489.32
£1,076,293
20,445 489.32 £1,076,293
2024-04-05 2024-04-05 B Purchase Glen Clack

Chief Medical Officer

Officer
31,641
54.54
£4,826,186
31,641 54.54 £4,826,186
2024-04-05 2024-04-05 B Purchase Dr Helen Kuhlman

Chief Business Officer

Officer
59,094
487.61
£2,933,662
59,094 487.61 £2,933,662
2024-04-05 2024-04-05 B Purchase Dr Susan Foden

Non-Executive Chair

Director
600,000
0.01
£6,000
600,000 0.01 £6,000
2024-04-05 2024-04-05 B Purchase Toni Hänninen

Chief Financial Officer

Officer
1,000,000
0.01
£10,000
1,000,000 0.01 £10,000
2024-04-05 2024-04-05 B Purchase Dr Huw Jones

Chief Executive Officer

Officer
3,000,000
0.01
£30,000
3,000,000 0.01 £30,000
2024-04-05 2024-04-05 B Purchase Dr Huw Jones

Chief Executive Officer

Officer
122,293
0.01
£1,761
122,293 0.01 £1,761
2021-03-05 2021-03-03 B Purchase Richard Moulson

CFO

Officer
3,787
0.08
£303
3,787 0.08 £303